Sanofi (SNY) Profit After Tax (2009 - 2026)

Sanofi has disclosed Profit After Tax across 18 years of filings, most recently posting $438.2 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 90.18% year-over-year to $438.2 million; the TTM figure through Jun 2026 stood at $14.8 billion (up 12.32% YoY), while the FY2025 annual figure was $9.1 billion, up 50.3% from the prior year.
• Profit After Tax came in at $438.2 million for Q2 2026 at Sanofi, down from $1.9 billion in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $10.1 billion in Q3 2025 to a low of $438.2 million in Q2 2026.
• Average Profit After Tax over 5 years is $2.8 billion, with a median of $2.1 billion recorded in 2023.
• Year-over-year, Profit After Tax soared 271.15% in 2025 and tumbled 90.18% in 2026.
• Over 5 years, Profit After Tax stood at $5.4 billion in 2022, then plunged by 60.72% to $2.1 billion in 2023, then surged by 68.29% to $3.6 billion in 2024, then plunged by 34.61% to $2.3 billion in 2025, then plunged by 81.31% to $438.2 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $438.2 million in Q2 2026, $1.9 billion in Q1 2026, and $2.3 billion in Q4 2025.